REGENEREX PHARMA, INC. Interest Payable, Current
REGENEREX PHARMA, INC. had Interest Payable, Current of $33.41 thousand as of 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-31
- 2025-12-31: Interest Payable, Current $33.41K.
- 2025-03-31: Interest Payable, Current $14.29K.
- 2024-03-31: Interest Payable, Current $69.39K.
- 2023-03-31: Interest Payable, Current $111.24K.
| Period end | Interest Payable, Current |
|---|---|
| 2025-12-31 | $33.41K 10-KT · filed 2026-08-31 |
| 2025-03-31 | $14.29K 10-KT · filed 2026-08-31 |
| 2024-03-31 | $69.39K 10-K · filed 2025-06-30 |
| 2023-03-31 | $111.24K 10-K · filed 2024-06-24 |
| 2022-03-31 | $74.75K 10-K · filed 2023-06-09 |
| 2021-03-31 | $58.50K 10-K · filed 2021-06-23 |
| 2021-03-21 | $58.50K 10-K · filed 2022-06-28 |
| 2020-03-31 | $29.44K 10-K · filed 2021-06-23 |
| 2019-03-31 | $778.00 10-K/A · filed 2020-08-11 |